The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[5-(benzylsulfanyl)-1,3,4-thiadiazol-2-yl]-4-phenyl-1,2,3-thiadiazole-5-carboxamide ID: ALA5283421
Max Phase: Preclinical
Molecular Formula: C18H13N5OS3
Molecular Weight: 411.54
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1nnc(SCc2ccccc2)s1)c1snnc1-c1ccccc1
Standard InChI: InChI=1S/C18H13N5OS3/c24-16(15-14(20-23-27-15)13-9-5-2-6-10-13)19-17-21-22-18(26-17)25-11-12-7-3-1-4-8-12/h1-10H,11H2,(H,19,21,24)
Standard InChI Key: MRESSJCBOZXVBG-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
-3.7434 1.8734 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.9184 1.8734 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.6682 1.0693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3217 0.5985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9893 1.0906 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.3217 -0.2261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8714 0.8558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2881 1.4391 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.6578 0.0591 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.8611 -0.1541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2779 0.4289 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.4670 0.0374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3377 -0.7573 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.4816 -0.8814 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.1814 0.4499 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.8958 0.0374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6100 0.4499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6103 1.2746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3229 1.6851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0374 1.2726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0390 0.4520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3275 0.0356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6076 -0.6387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6084 -1.4609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3228 -1.8734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0343 -1.4645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0390 -0.6402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
1 5 2 0
5 4 1 0
4 6 1 0
3 7 1 0
7 8 2 0
7 9 1 0
9 10 1 0
11 10 1 0
11 12 1 0
12 13 2 0
14 13 1 0
10 14 2 0
12 15 1 0
15 16 1 0
16 17 1 0
18 17 2 0
19 18 1 0
20 19 2 0
21 20 1 0
22 21 2 0
17 22 1 0
23 6 2 0
24 23 1 0
25 24 2 0
26 25 1 0
27 26 2 0
6 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 411.54Molecular Weight (Monoisotopic): 411.0282AlogP: 4.60#Rotatable Bonds: 6Polar Surface Area: 80.66Molecular Species: ACIDHBA: 8HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.40CX Basic pKa: ┄CX LogP: 5.21CX LogD: 4.35Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.37Np Likeness Score: -2.42
References 1. Dodd CJ, Chronister KS, Rathnayake U, Parr LC, Li K, Chang S, Mi D, Days EL, Bauer JA, Cho HP, Boutaud O, Denton JS, Lindsley CW, Han C.. (2023) Synthesis and SAR of a novel Kir6.2/SUR1 channel opener scaffold identified by HTS., 87 [PMID:36966977 ] [10.1016/j.bmcl.2023.129256 ]